首页> 外国专利> DRUG FOR TREATING VASCULAR DISEASE OR DRUG FOR CONTROLLING CELL PROLIFERATION COMPRISING RIFAMYCIN DERIVATIVE AS THE ACTIVE INGREDIENT

DRUG FOR TREATING VASCULAR DISEASE OR DRUG FOR CONTROLLING CELL PROLIFERATION COMPRISING RIFAMYCIN DERIVATIVE AS THE ACTIVE INGREDIENT

机译:用于治疗血管疾病的药物或用于控制以利福霉素衍生物为有效成分的细胞增殖的药物

摘要

It is intended to provide a drug for treating a vascular disease or a drug for controlling cell proliferation to be used for preventing and treating a vascular disease such as restenosis after percutaneous angioplasty. This problem can be solved by a drug for treating a vascular disease or a drug for controlling cell proliferation comprising as the active ingredient a Rifamycin derivative which strongly inhibits the proliferation of vascular smooth muscle compared with vascular endothelial cells. Such preparations, etc. comprising the Rifamycin derivative as the active ingredient are useful in preventing or treating vascular diseases (for example, arteriosclerosis, aneurysm, false aneurysm, arterial dissection, an inflammatory arterial disease, a non-inflammatory arterial disease, hemodialysis shunt, restenosis and reobstruction after percutaneous angioplasty).
机译:旨在提供用于治疗和预防血管疾病的药物或用于控制细胞增殖的药物,以用于预防和治疗诸如经皮血管成形术后的再狭窄的血管疾病。该问题可以通过治疗血管疾病的药物或控制细胞增殖的药物来解决,该药物包含利福霉素衍生物作为有效成分,与血管内皮细胞相比,该利福霉素衍生物强烈抑制血管平滑肌的增殖。包含利福霉素衍生物作为有效成分的此类制剂等可用于预防或治疗血管疾病(例如,动脉硬化,动脉瘤,假性动脉瘤,动脉夹层,炎性动脉疾病,非炎性动脉疾病,血液透析分流,经皮血管成形术后再狭窄和再梗阻)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号